https://seliciclibinhibitor.co....m/folic-acid-b-vitam
Sixty patients, aged a collective 605 years (with an age range of 510-650 years) and comprising 233 females, were treated with venovenous/venoarterial ECMO for COVID-19 between April 2020 and September 2021. The percentage of patients weaned off ECMO reached 417%, demonstrating a remarkable 400% survival rate to discharge (n = 24). Patients exhibiting ages of 630 (600-668) years and 550 (438-60 years, burdened with histories of neoplasia
Like
Comment
Share
